Getty ImagesShares of Aurobindo Pharma Ltd. slipped 0.24 per cent to Rs 648.35 in Tuesday's trade as of 11:52AM (IST). It hit a high of Rs 657.6 and low of Rs 643.55 during the session.
The stock quoted a 52-week high price of Rs 1063.75 and a low of Rs 590.25. The return on equity for the stock stood at 24.32 per cent. About 37,719 shares have changed hands on the counter so far.
The stock's beta value, which measures its volatility in relation to the broader market, stood at 1.06.
The scrip has been an underperformer, down 32.26 per cent in the past one year in comparison with a 18.96 per cent gain in Sensex.
Technicals
On the technical charts, the 200-day moving average (DMA) of the stock stood at Rs 590.25 on February 08, while the 50-DMA was at Rs 686.56. If a stock trades well above 50-DMA and 200-DMA, it usually means the immediate trend is upward. On the other hand, if the stock trades well below 50-DMA and 200-DMA both, it is considered a bearish trend and if trades between these averages, then it suggests the stock can go either way.
Promoter/FII Holding
Promoters held 48.76 per cent stake in Aurobindo Pharma Ltd. as of 31-Dec-2021. Mutual funds and foreign institutional investors held 9.56 per cent and 21.37 per cent stake.
The stock quoted a 52-week high price of Rs 1063.75 and a low of Rs 590.25. The return on equity for the stock stood at 24.32 per cent. About 37,719 shares have changed hands on the counter so far.
The stock's beta value, which measures its volatility in relation to the broader market, stood at 1.06.
The scrip has been an underperformer, down 32.26 per cent in the past one year in comparison with a 18.96 per cent gain in Sensex.
Technicals
On the technical charts, the 200-day moving average (DMA) of the stock stood at Rs 590.25 on February 08, while the 50-DMA was at Rs 686.56. If a stock trades well above 50-DMA and 200-DMA, it usually means the immediate trend is upward. On the other hand, if the stock trades well below 50-DMA and 200-DMA both, it is considered a bearish trend and if trades between these averages, then it suggests the stock can go either way.
Promoter/FII Holding
Promoters held 48.76 per cent stake in Aurobindo Pharma Ltd. as of 31-Dec-2021. Mutual funds and foreign institutional investors held 9.56 per cent and 21.37 per cent stake.
Pick the best companies to invest
BECOME AN ETPRIME MEMBERRead More News on
(What's moving Sensex and Nifty Track latest market news, stock tips and expert advice on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds.)
...moreDownload The Economic Times News App to get Daily Market Updates & Live Business News.
Pick the best stocks for yourself
Powered by